KMS Medisurgi Ltd

KMS Medisurgi Limited has informed the stock exchange that a report on Corporate Governance is not applicable to the company for the quarter ended September 30, 2026. This is in accordance with Regulation 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The exemption applies to listed entities with paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore, or those listed on the SME Exchange. As KMS Medisurgi is listed on the BSE SME Platform, it is exempt from submitting the detailed corporate governance report.

KMS Medisurgi Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be closed effective October 1, 2026, and will reopen 48 hours after the declaration of the company's financial results for the half-year ended September 30, 2026. Designated individuals are prohibited from trading in the company's securities during this period. The date of the board meeting to approve these financial results will be communicated separately.

KMS Medisurgi Limited has submitted its Annual Report for the Financial Year 2026, as per SEBI regulations. The report includes the Standalone Financial Statements, Directors' Report, and Auditor's Report. Key highlights include the proposed declaration of a final dividend of ₹0.05 per equity share and the re-appointment of Mr. Rohan Devang Kanakia as a Director. The 28th Annual General Meeting is scheduled for September 30, 2026, to adopt the financial statements and approve the dividend.

KMS Medisurgi Ltd announced that its Board of Directors has recommended a final dividend of ₹0.05 (0.5%) per equity share for the financial year ended March 31, 2026. This recommendation is subject to shareholder approval at the upcoming 28th Annual General Meeting (AGM) scheduled for September 30, 2026. The company also informed about the closure of the Register of Members and Share Transfer Books from September 24 to September 30, 2026, and fixed September 23, 2026, as the record date for determining eligible shareholders for the dividend. The Board meeting also approved the Directors' Report, Balance Sheet, Profit & Loss Account, Cash Flow, and Auditors' Report for FY 2025-26.

KMS Medisurgi Ltd has announced the record date for the payment of its dividend. The company's Register of Members and Share Transfer books will be closed from September 24, 2026, to September 30, 2026, inclusive. This closure is for the purpose of recording members eligible for the dividend payment. The dividend amount is ₹0.05 (0.5%) per equity share for the financial year ended March 31, 2026. The record date for this dividend payment has been set as September 23, 2026.

KMS Medisurgi Limited has announced its 28th Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 3:00 p.m. at its registered office in Mumbai. The agenda includes the adoption of the standalone financial statements for the financial year ended March 31, 2026, the declaration of a final dividend of ₹0.05 per equity share, and the re-appointment of Mr. Rohan Devang Kanakia as a Director liable to retire by rotation. The notice also details procedures for proxy appointments, register closure dates, and voting rights.

KMS Medisurgi Ltd's Board of Directors has recommended a final dividend of ₹0.05 (0.5%) per equity share for the financial year ended March 31, 2026. This recommendation is subject to shareholder approval at the upcoming 28th Annual General Meeting (AGM) scheduled for September 30, 2026. The record date for determining eligible shareholders is September 23, 2026, and the register of members will be closed from September 24 to September 30, 2026. The board also approved the Directors' Report, financial statements, and secretarial audit report for FY 2025-26.

KMS Medisurgi Ltd announced that its Board of Directors has approved holding the 28th Annual General Meeting (AGM) on Wednesday, September 30, 2026. The board also recommended a final dividend of ₹0.05 per equity share for the financial year ended March 31, 2026, subject to shareholder approval. The company will present the Directors' Report, Balance Sheet, Profit & Loss Account, Cash Flow, and Auditors' Report for FY 2025-26 at the AGM. The Register of Members and Share Transfer Books will be closed from September 24 to September 30, 2026, with September 23, 2026, fixed as the record date for dividend eligibility. M/s. Naveen Karn & Associates has been appointed as the scrutinizer for the e-voting process.

KMS Medisurgi Ltd has announced that its Board of Directors will convene on September 5, 2026. The meeting agenda includes crucial items such as approving the date, time, and venue for the 28th Annual General Meeting (AGM), along with the Directors' Report and Notice for the AGM. The board will also consider and recommend the financial statements for the fiscal year ended March 31, 2026, and the Management Discussion and Analysis Report. Additionally, they will discuss the closure of the Register of Members and Share Transfer Books, potential final dividend, and the appointment of a scrutinizer for the AGM's voting process.

KMS Medisurgi Ltd has informed the exchange that it is not required to submit the Corporate Governance Report for the quarter ended June 30, 2026. This exemption is due to the company being listed on the BSE SME Platform, and meeting the criteria under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Specifically, the company's paid-up equity share capital and net worth fall below the thresholds that mandate compliance with certain corporate governance provisions.